<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:158.5pt;left:42.5pt;line-height:9.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:9.8pt">Original article</span></p>
<p style="top:177.2pt;left:42.5pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">Recombinant human activated protein C as a disease modi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:13.7pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">er in severe acute</span></p>
<p style="top:194.5pt;left:42.5pt;line-height:13.7pt"><span style="font-family:AdvOT863180fb,serif;font-size:13.7pt">pancreatitis: Systematic review of current evidence</span></p>
<p style="top:219.6pt;left:42.5pt;line-height:10.8pt"><span style="font-family:AdvOT863180fb,serif;font-size:10.8pt">Charles J. Miranda, Benoy I. Babu, Ajith K. Siriwardena</span><sup><span style="font-family:AdvP4C4E59,serif;font-size:7.8pt;color:#000066">*</span></sup></p>
<p style="top:238.0pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Hepatobiliary Surgery Unit, Manchester Royal In</span><span style="font-family:AdvOTb92eb7df.I+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">rmary, Oxford Road, Manchester M13 9WL, UK</span></p>
<p style="top:288.3pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">Keywords:</span></p>
<p style="top:296.9pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Human recombinant activated protein C</span></p>
<p style="top:305.4pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Drotecogin Alfa</span></p>
<p style="top:314.0pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Pancreatitis</span></p>
<p style="top:268.8pt;left:206.9pt;line-height:9.1pt"><span style="font-family:AdvOTc4d0b532,serif;font-size:9.1pt">a b s t r a c t</span></p>
<p style="top:289.7pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Background:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> The severity of organ failure caused by acute pancreatitis (AP) is the most important</span></p>
<p style="top:299.3pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">determinant of mortality in the disease. Recombinant human activated protein C (Drotrecogin Alfa;</span></p>
<p style="top:308.9pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">Xigris, APC, rhAPC) is the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">rst drug to show a decrease in all-cause mortality due to multiple organ failure</span></p>
<p style="top:318.4pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">caused by sepsis. As the systemic in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">ammatory response syndrome (SIRS) that causes organ failure in</span></p>
<p style="top:328.0pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">early AP is similar to that caused by severe sepsis, the use of rhAPC in the management of AP has been</span></p>
<p style="top:337.5pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">investigated in experimental and clinical studies which are collated in this review.</span></p>
<p style="top:347.1pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Methods:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> A literature review of published material identi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">ed from MEDLINE and EMBASE databases, for</span></p>
<p style="top:356.7pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">the period from January 1985 to January 2011, reporting rhAPC usage in AP.</span></p>
<p style="top:366.3pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Results:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> 3 of 4 experimental studies reported an improvement in outcome in animals with AP given</span></p>
<p style="top:375.8pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">rhAPC. The clinical randomized trial showed no improvement in outcome in the treatment arm.</span></p>
<p style="top:385.4pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:7.3pt">Conclusion:</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> The experimental evidence of disease amelioration in AP following intervention with rhAPC</span></p>
<p style="top:395.0pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">has not translated to the small clinical RCT. Given that there were only 16 patients in the treatment arm,</span></p>
<p style="top:404.5pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">further clinical evaluation is justi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:7.3pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">ed.</span></p>
<p style="top:414.1pt;left:206.9pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">Copyright</span><span style="font-family:AdvPSSym,serif;font-size:7.3pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt"> 2012, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All</span></p>
<p style="top:423.7pt;left:509.2pt;line-height:7.3pt"><span style="font-family:AdvOT863180fb,serif;font-size:7.3pt">rights reserved.</span></p>
<p style="top:467.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">1. Introduction</span></p>
<p style="top:488.3pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Severe acute pancreatitis (SAP) is characterized by the co-</span></p>
<p style="top:498.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">existence of local peri-pancreatic complications with sustained</span></p>
<p style="top:509.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">organ failure</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [1]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The treatment remains essentially supportive and</span></p>
<p style="top:519.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">comprises careful and adequate</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uid resuscitation together with</span></p>
<p style="top:530.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">support for cardiovascular, respiratory and renal systems in addi-</span></p>
<p style="top:540.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tion to appropriate analgesia</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [2,3]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Prophylactic antibiotic therapy</span></p>
<p style="top:551.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">[4</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#000066">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">6]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, early enteral nutrition</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [7,8]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and early endoscopic sphinc-</span></p>
<p style="top:561.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">terotomy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [9]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> for patients with biliary acute pancreatitis and</span></p>
<p style="top:572.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">features of bile duct obstruction are the only speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c interventions</span></p>
<p style="top:582.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for which there is supportive randomized trial evidence. However,</span></p>
<p style="top:593.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">none of these interventions are universally accepted as genuinely</span></p>
<p style="top:603.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ameliorating the disease course and in the case of antibiotics in</span></p>
<p style="top:613.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">particular, current guidance does not favor prophylaxis.</span></p>
<p style="top:624.3pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Given that the early stage of severe acute pancreatitis does not</span></p>
<p style="top:634.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">require surgical intervention</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [10,11]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, this phase of the disease is</span></p>
<p style="top:645.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ideally and logically suited to pharmacological intervention aimed</span></p>
<p style="top:655.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">at disease modi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cation. Many drugs have been evaluated as speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c</span></p>
<p style="top:666.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pharmacological</span></p>
<p style="top:666.2pt;left:114.1pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatments</span></p>
<p style="top:666.2pt;left:164.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for</span></p>
<p style="top:666.2pt;left:184.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">severe</span></p>
<p style="top:666.2pt;left:217.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">acute</span></p>
<p style="top:666.2pt;left:247.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis.</span></p>
<p style="top:467.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Disappointingly, the unifying characteristic of the drugs that have</span></p>
<p style="top:477.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">been evaluated to date has been their lack of ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy as effective</span></p>
<p style="top:488.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">disease-ameliorating treatments for severe acute pancreatitis.</span></p>
<p style="top:498.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Whilst it is thought that some of this apparent lack of ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy may</span></p>
<p style="top:509.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">relate to the over-broad categorization of severe acute pancreatitis</span></p>
<p style="top:519.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in the 1992 Atlanta consensus criteria</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [1]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> resulting in patients with</span></p>
<p style="top:530.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">transient or minimal organ failure (and thus a likely mild clinical</span></p>
<p style="top:540.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">course) being incorrectly categorized as severe, it remains the case</span></p>
<p style="top:551.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">that there is to date, no speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c pharmacological treatment for</span></p>
<p style="top:561.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">severe acute pancreatitis.</span></p>
<p style="top:572.1pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">One strategy in the search for speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c interventions is to</span></p>
<p style="top:582.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">consider treatments that have been effective in disease states that</span></p>
<p style="top:593.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">are similar to SAP. Severe sepsis has similarities to SAP; both are</span></p>
<p style="top:603.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">characterized by an exaggerated systemic in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory response</span></p>
<p style="top:613.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">syndrome (SIRS). In</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammation involves a pathophysiological</span></p>
<p style="top:624.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">derangement of the endogenous anticoagulant pathways involved</span></p>
<p style="top:634.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in the maintenance of microvascular patency</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [12]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> with microvas-</span></p>
<p style="top:645.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cular thrombosis and disseminated intravascular coagulation being</span></p>
<p style="top:655.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a critical outcome</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [13]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The protein C pathway plays a major role in</span></p>
<p style="top:666.2pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">preventing microvascular thrombosis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [14]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Endogenous protein C is</span></p>
<p style="top:676.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">depleted in a primate model of</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> Escherichia coli</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">-induced sepsis</span></p>
<p style="top:687.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">resulting in microvascular thrombosis, the harmful effects of which</span></p>
<p style="top:697.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">are ameliorated by intravenous infusion of recombinant human</span></p>
<p style="top:708.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">active protein C molecule (rhAPC)</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [15]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Based on these key</span></p>
<p style="top:701.1pt;left:47.6pt;line-height:6.5pt"><span style="font-family:AdvP4C4E59,serif;font-size:6.5pt">*</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Corresponding author. Tel.:</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">44 161 276 4250; fax:</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">44 161 276 4530.</span></p>
<p style="top:709.8pt;left:54.5pt;line-height:6.5pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt">E-mail address:</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> ajith.siriwardena@cmft.nhs.uk</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> (A.K. Siriwardena).</span></p>
<img style="position:absolute;transform:matrix(.4796055,0,-0,.47928656,12.161331,48.71263)" src="data:image/jpeg;base64,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">
<p style="top:73.3pt;left:207.9pt;line-height:8.1pt"><span style="font-family:AdvPSA35D,serif;font-size:8.1pt">Contents lists available at</span><span style="font-family:AdvPSA35D,serif;font-size:8.1pt;color:#000066"> SciVerse ScienceDirect</span></p>
<p style="top:97.4pt;left:257.4pt;line-height:14.2pt"><span style="font-family:AdvOT863180fb,serif;font-size:14.2pt">Pancreatology</span></p>
<p style="top:129.2pt;left:188.2pt;line-height:8.1pt"><span style="font-family:AdvPSA35D,serif;font-size:8.1pt">journal homepage: www.elsevier.com/locate/pan</span></p>
<img style="position:absolute;transform:matrix(.4796372,0,-0,.47937025,633.6127,37.743989)" src="data:image/jpeg;base64,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">
<p style="top:728.3pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1424-3903/$</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> see front matter Copyright</span><span style="font-family:AdvPSSym,serif;font-size:6.5pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 2012, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.</span></p>
<p style="top:736.9pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">doi:</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066">10.1016/j.pan.2012.01.002</span></p>
<p style="top:47.8pt;left:253.4pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#000066">Pancreatology 12 (2012) 119</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt;color:#000066">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt;color:#000066">123</span></p>


<p style="top:66.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">experimental</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings, human recombinant activated protein C</span></p>
<p style="top:76.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(Xigris, Eli Lilly, Indianapolis, IN) was evaluated in a major</span></p>
<p style="top:87.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">randomized trial in patients with sepsis (the PROWESS study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [16]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">).</span></p>
<p style="top:97.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The PROWESS study demonstrated that treatment was associated</span></p>
<p style="top:108.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with a signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant reduction in mortality.</span></p>
<p style="top:118.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">SAP is characterized by pancreatic and peri-pancreatic necrosis</span></p>
<p style="top:128.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in addition to SIRS. Microvascular thrombosis is likely to be one of</span></p>
<p style="top:139.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the mechanisms involved in the mediation of pancreatic necrosis.</span></p>
<p style="top:149.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Thus a hypothetical case can be made that Xigris may have a role as</span></p>
<p style="top:160.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">an early and speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c disease-modulating drug in SAP for its roles in</span></p>
<p style="top:170.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">maintaining microvascular patency and down regulating the</span></p>
<p style="top:181.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory response.</span></p>
<p style="top:191.7pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">An important caveat is that acute pancreatitis was one of the</span></p>
<p style="top:202.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">listed exclusion criteria in the PROWESS study [Appendix 2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [16]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">].</span></p>
<p style="top:212.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">SAP is associated with a risk of peri-pancreatic hemorrhage and</span></p>
<p style="top:223.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">thus the use of a drug with potent anticoagulant properties may</span></p>
<p style="top:233.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lead to bleeding-related complications.</span></p>
<p style="top:243.9pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The potential role of rhAPC as a speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c pharmacological treat-</span></p>
<p style="top:254.4pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ment for SAP was recognized by Alsfasser and colleagues who</span></p>
<p style="top:264.9pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">undertook the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst evaluation of this drug in this setting</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Since</span></p>
<p style="top:275.3pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">their initial report, experience with RHAPC in experimental acute</span></p>
<p style="top:285.8pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis has accrued and a small clinical randomized trial has</span></p>
<p style="top:296.3pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">also been undertaken.</span></p>
<p style="top:306.7pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Considering the history of unsuccessful pharmacological inter-</span></p>
<p style="top:317.2pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ventions in SAP the aim of this study is to undertake a detailed</span></p>
<p style="top:327.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">systematic review of the evidence for rhAPC as a disease modi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">er</span></p>
<p style="top:338.1pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and to address whether there is suf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient evidence for an appro-</span></p>
<p style="top:348.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">priately constituted randomized trial to evaluate this drug in SAP.</span></p>
<p style="top:374.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">2. Methods</span></p>
<p style="top:395.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">2.1. Literature search and data retrieval strategy</span></p>
<p style="top:416.6pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">A computerized search was performed of the MEDLINE and</span></p>
<p style="top:427.0pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">EMBASE databases for the period from January 1985 to January</span></p>
<p style="top:437.5pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">2011 using the OVID search engine (Version 10.5.1, Source ID</span></p>
<p style="top:447.9pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">1.13281.2.21; Ovid Technologies, Inc., New York, NY, USA). The</span></p>
<p style="top:458.4pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">search terms</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Pancreatitis</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Protein C</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt"> &#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Activated Protein C</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and</span></p>
<p style="top:468.9pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2018;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Drotrecogin</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> were used. The map term to subject (MeSH) heading</span></p>
<p style="top:479.3pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">was employed where possible. Results were combined with the</span></p>
<p style="top:489.8pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">keywords, with the aid of Boolean operators. There were 23 hits in</span></p>
<p style="top:500.3pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">MEDLINE and 61 in EMBASE. The Cochrane systematic reviews</span></p>
<p style="top:510.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">methodology was utilized to cross-reference combined EMBASE</span></p>
<p style="top:521.2pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and MEDLINE output with all clinical trials and studies including</span></p>
<p style="top:531.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">experimental studies and any non-English studies. Letters and</span></p>
<p style="top:542.1pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reviews without original data were excluded, leaving a</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal study</span></p>
<p style="top:552.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">population of 8 manuscripts. The reasons for excluding manu-</span></p>
<p style="top:563.0pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">scripts are provided in</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> Fig. 1</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:573.5pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">All retrieved manuscripts were reviewed by two authors (CJM,</span></p>
<p style="top:583.9pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">BIB) and any difference of opinion regarding</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nal inclusion/exclu-</span></p>
<p style="top:594.4pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">sion was resolved by discussion with the third author (AKS).</span></p>
<p style="top:620.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">3. Results</span></p>
<p style="top:641.5pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.1. Human recombinant activated protein C in experimental acute</span></p>
<p style="top:652.0pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">pancreatitis</span></p>
<p style="top:672.9pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Four studies have evaluated the role of rhAPC in experimental</span></p>
<p style="top:683.3pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">acute pancreatitis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#000066">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">20]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> (</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">Tables 1 and 2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">). Of these, a further study</span></p>
<p style="top:693.8pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">by Chen</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s group was excluded, as there is a considerable apparent</span></p>
<p style="top:704.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">overlap between the 2007 study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [19]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and the 2010 report</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [21]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:714.7pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">All experimental studies have evaluated experimental acute</span></p>
<p style="top:725.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitisintheratmodel.Therearenodataon largeanimalmodels</span></p>
<p style="top:735.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of acute pancreatitis. All use a well-validated intra-ductal infusion</span></p>
<p style="top:515.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">method to induce acute pancreatitis. A wide range of concentrations</span></p>
<p style="top:525.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of human recombinant activated protein C is evaluated.</span></p>
<p style="top:536.3pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings are not consistent. Yamanel and colleagues</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [18]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">,</span></p>
<p style="top:546.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">using 100 mg/kg rhAPC as a single dose at 6 h after induction,</span></p>
<p style="top:557.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">report improvements in histologic features of pancreatic injury,</span></p>
<p style="top:567.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">serum markers of in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammation and a reduction in bacterial</span></p>
<p style="top:578.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">translocation. There was no evidence of pancreatic or intra-</span></p>
<p style="top:588.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">abdominal hemorrhage.</span></p>
<p style="top:599.1pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Alsfasser</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> comprehensive report describes a concentra-</span></p>
<p style="top:609.6pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tion-dependent thrombocytopenia but no effect of the drug on</span></p>
<p style="top:620.0pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">histologic scores of necrosis and edema with the 100</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.7pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">g/kg/h</span></p>
<p style="top:630.5pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">continuous infusion. The Alsfasser group is the only study to</span></p>
<p style="top:640.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">examine mortality and they show a signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant reduction in</span></p>
<p style="top:651.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mortality in animals with AP treated with rhAPC compared to</span></p>
<p style="top:661.9pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">animals with AP alone.</span></p>
<p style="top:672.3pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Chen</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [19]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> provides detailed information on the effect of</span></p>
<p style="top:682.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rhAPC on the mitogen-associated protein kinase pathway demon-</span></p>
<p style="top:693.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">strating a reduction in expression of stress proteins.</span></p>
<p style="top:703.7pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The Akay study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [20]</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings are in contrast to the others in that</span></p>
<p style="top:714.2pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">they report no bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cial effects from intervention with rhAPC. Of</span></p>
<p style="top:724.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">note, the concentration of rhAPC used in their study parallels the</span></p>
<p style="top:735.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">dose used in human sepsis (24</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.7pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">g/kg/h).</span></p>
<img style="position:absolute;transform:matrix(.4799393,0,-0,.4798647,229.87,-207.78662)" src="data:image/jpeg;base64,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">
<p style="top:488.2pt;left:301.8pt;line-height:6.4pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.4pt">Fig. 1.</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt"> Search strategy. Date range from January 1985 to January 2011. rhAPC</span><span style="font-family:AdvP4C4E74,serif;font-size:6.4pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt"> human</span></p>
<p style="top:496.8pt;left:301.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">recombinant activated protein C. AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.4pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt"> acute pancreatitis.</span></p>
<p style="top:47.8pt;left:217.1pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">C.J. Miranda et al. / Pancreatology 12 (2012) 119</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">123</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">120</span></p>


<p style="top:355.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">3.2. Human recombinant activated protein C in clinical acute</span></p>
<p style="top:366.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt">pancreatitis</span></p>
<p style="top:387.0pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The APCAP study comprised a pilot, double blind, randomized</span></p>
<p style="top:397.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">placebo-controlled trial (RCT) of intravenous infusion of rhAPC at</span></p>
<p style="top:407.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">xed dose of 24</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.7pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">g/kg/h for 96 h in patients with SAP</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. The</span></p>
<p style="top:418.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">inclusion criteria were appropriately focused to deliver a target</span></p>
<p style="top:428.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">population with severe disease:</span><span style="font-family:AdvP4C4E51,serif;font-size:8.1pt"> &lt;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">96 h from onset of pain and at</span></p>
<p style="top:439.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">least one organ dysfunction (de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ned as organ speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c Sequential</span></p>
<p style="top:449.8pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Organ Failure Assessment (SOFA) score of at least 3 or 4, within 48 h</span></p>
<p style="top:460.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of onset of the</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst organ dysfunction).</span></p>
<p style="top:470.7pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:8.1pt"> a priori</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> primary endpoint was a three-point difference in</span></p>
<p style="top:481.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">change of SOFA score with the authors predicting that this differ-</span></p>
<p style="top:491.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ence could be detected with a sample size of 32 patients were</span></p>
<p style="top:502.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">randomized and 16 patients comprised the intervention group.</span></p>
<p style="top:512.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Baseline characteristics were similar and the mean</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> standard</span></p>
<p style="top:355.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">deviation Acute Physiological and Chronic Health Evaluation II</span></p>
<p style="top:366.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(APACHE II) score in the rhAPC group was 17.6</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 8.5.</span></p>
<p style="top:376.5pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Their results showed no signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant bleeding events. The 30-day</span></p>
<p style="top:387.0pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mortality in the rhAPC group was 3 (19%) compared to 0 in the</span></p>
<p style="top:397.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">placebo group. The primary endpoint was not met and there was no</span></p>
<p style="top:407.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant difference in SOFA score. An interesting observation was</span></p>
<p style="top:418.4pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">that treatment with rhAPC was associated with an increase in serum</span></p>
<p style="top:428.9pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">levels of both total and conjugated bilirubin. There were no differ-</span></p>
<p style="top:439.3pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ences in ventilator-free days, in renal replacement therapy-free</span></p>
<p style="top:449.8pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">days, in vasopressor-free days or in days alive outside the hospital.</span></p>
<p style="top:460.2pt;left:323.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In addition to this principal randomized trial, there are case</span></p>
<p style="top:470.7pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">report-level experiences of the use of rhAPC in severe acute</span></p>
<p style="top:481.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis. The</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rst documented report of rhAPC use in severe</span></p>
<p style="top:491.6pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">acute pancreatitis was by Machala and colleagues who reported</span></p>
<p style="top:502.1pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">their</span></p>
<p style="top:502.1pt;left:336.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">experience</span></p>
<p style="top:502.1pt;left:385.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with</span></p>
<p style="top:502.1pt;left:410.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">2</span></p>
<p style="top:502.1pt;left:421.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients</span></p>
<p style="top:502.1pt;left:459.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with</span></p>
<p style="top:502.1pt;left:484.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">infected</span></p>
<p style="top:502.1pt;left:522.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatic</span></p>
<p style="top:512.5pt;left:311.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">necrosis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [23]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In 2006, Grochowiecki and colleagues published</span></p>
<p style="top:66.2pt;left:43.4pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 1</span></p>
<p style="top:74.8pt;left:43.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Protocol details of studies evaluating human recombinant activated protein C in experimental acute pancreatitis. rhAPC</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Human recombinant activated protein C; AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Acute</span></p>
<p style="top:83.4pt;left:43.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Pancreatitis; i.v.</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Intravenous; MAPK</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> mitogen-activated protein kinases. CNI1493: a synthetic inhibitor of signal transduction, which inhibits phosphorylation of p38 MAPK.</span></p>
<p style="top:97.5pt;left:49.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">First author</span></p>
<p style="top:97.5pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Animal</span></p>
<p style="top:106.1pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">model</span></p>
<p style="top:97.5pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study designation/</span></p>
<p style="top:106.1pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">detail</span></p>
<p style="top:97.5pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Induction agent/route</span></p>
<p style="top:97.5pt;left:316.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Concentration of Xigris</span></p>
<p style="top:97.5pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Groups</span></p>
<p style="top:97.5pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Number of</span></p>
<p style="top:106.1pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">animals</span></p>
<p style="top:97.5pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study</span></p>
<p style="top:106.1pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">duration</span></p>
<p style="top:117.5pt;left:49.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yamanel</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [18]</span></p>
<p style="top:126.1pt;left:57.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2005</span></p>
<p style="top:117.5pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rat</span></p>
<p style="top:117.5pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Effect of rhAPC</span></p>
<p style="top:126.1pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">on AP</span></p>
<p style="top:117.5pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal 5% sodium</span></p>
<p style="top:126.1pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">taurocholate</span></p>
<p style="top:117.5pt;left:316.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">100 mg/kg single dose at</span></p>
<p style="top:126.1pt;left:316.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6 h after induction</span></p>
<p style="top:117.5pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group I</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> control</span></p>
<p style="top:126.1pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group II</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> AP</span></p>
<p style="top:134.7pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group III</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> rhAPC</span></p>
<p style="top:117.6pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">45</span></p>
<p style="top:117.6pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24 h</span></p>
<p style="top:143.3pt;left:49.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [17]</span></p>
<p style="top:151.9pt;left:57.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2006</span></p>
<p style="top:143.3pt;left:103.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rat</span></p>
<p style="top:143.3pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Safety assessment</span></p>
<p style="top:151.9pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">of rhAPC</span></p>
<p style="top:143.3pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal saline plus i.v. cerulein</span></p>
<p style="top:151.9pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg/h for mild AP</span></p>
<p style="top:160.4pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal 10 mM glycodeoxycholic</span></p>
<p style="top:169.0pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">acid</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">glycylglycine and i.v.</span></p>
<p style="top:177.5pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cerulein (as above)</span></p>
<p style="top:143.3pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">0.6 mL/kg/h or 100</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg/h</span></p>
<p style="top:151.8pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Continuous infusion</span></p>
<p style="top:143.3pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Dose-ranging study: 12.5,</span></p>
<p style="top:151.8pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">17, 21, 50 and</span></p>
<p style="top:160.4pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">100</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg/h rhAPC</span></p>
<p style="top:143.3pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">15</span></p>
<p style="top:151.8pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">(3 per</span></p>
<p style="top:160.4pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">group)</span></p>
<p style="top:143.3pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6 h</span></p>
<p style="top:186.1pt;left:49.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [17]</span></p>
<p style="top:194.7pt;left:57.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2006</span></p>
<p style="top:186.1pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rat</span></p>
<p style="top:186.1pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Treatment of</span></p>
<p style="top:194.7pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">severe AP</span></p>
<p style="top:186.1pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal 10 mM glycodeoxycholic</span></p>
<p style="top:194.7pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">acid</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">glycylglycine and i.v. cerulein</span></p>
<p style="top:186.1pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">100</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg/h</span></p>
<p style="top:194.6pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Continuous infusion</span></p>
<p style="top:186.1pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group 5: severe AP</span></p>
<p style="top:194.6pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group 6: severe AP</span></p>
<p style="top:203.2pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">and rhAPC</span></p>
<p style="top:186.1pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24</span></p>
<p style="top:194.6pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">(12 per</span></p>
<p style="top:203.2pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">group)</span></p>
<p style="top:186.1pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6 h</span></p>
<p style="top:211.8pt;left:49.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [17]</span></p>
<p style="top:220.4pt;left:57.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2006</span></p>
<p style="top:211.8pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rat</span></p>
<p style="top:211.8pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC &amp; survival</span></p>
<p style="top:211.8pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal 10 mM glycodeoxycholic</span></p>
<p style="top:220.4pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">acid</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">glycylglycine and i.v. cerulein</span></p>
<p style="top:211.8pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">100</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg/h</span></p>
<p style="top:220.4pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Continuous infusion</span></p>
<p style="top:211.8pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group 7: severe AP</span></p>
<p style="top:220.4pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Group 8: severe AP</span></p>
<p style="top:228.9pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">and rhAPC</span></p>
<p style="top:211.8pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">16</span></p>
<p style="top:220.4pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">(2 groups)</span></p>
<p style="top:211.8pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24 h</span></p>
<p style="top:237.5pt;left:49.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Chen</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [19]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 2007</span></p>
<p style="top:237.5pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rat</span></p>
<p style="top:237.5pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Effect of rhAPC</span></p>
<p style="top:246.1pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">on MAPK</span></p>
<p style="top:237.5pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal 5% sodium taurocholate</span></p>
<p style="top:237.5pt;left:316.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">10</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg (low dose) or</span></p>
<p style="top:246.1pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">50</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg (high dose)</span></p>
<p style="top:237.5pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5 groups:</span></p>
<p style="top:246.1pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Control</span></p>
<p style="top:254.6pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span></p>
<p style="top:263.2pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> rhAPC low</span></p>
<p style="top:271.8pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">dose (10</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg)</span></p>
<p style="top:280.4pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> rhAPC high</span></p>
<p style="top:288.9pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">dose (50</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg)</span></p>
<p style="top:297.5pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> CNI1493</span><span style="font-family:AdvP4C4E59,serif;font-size:6.5pt">*</span></p>
<p style="top:237.5pt;left:490.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">75</span></p>
<p style="top:237.5pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">16 h</span></p>
<p style="top:306.0pt;left:49.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Akay</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [20]</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> 2008</span></p>
<p style="top:306.0pt;left:103.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Rat</span></p>
<p style="top:306.0pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Effect of rhAPC</span></p>
<p style="top:314.6pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">on early phase</span></p>
<p style="top:323.2pt;left:132.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">of AP</span></p>
<p style="top:306.0pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Intra-ductal 5% sodium</span></p>
<p style="top:314.6pt;left:195.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">taurocholate</span></p>
<p style="top:306.0pt;left:316.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">24</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">g/kg/h as i.v. bolus</span></p>
<p style="top:314.6pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">starting 4 h after induction</span></p>
<p style="top:323.2pt;left:316.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">of AP</span></p>
<p style="top:306.0pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Laparotomy only</span></p>
<p style="top:314.6pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span></p>
<p style="top:323.2pt;left:405.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xfe;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> drotrecogin</span></p>
<p style="top:306.1pt;left:530.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9 h</span></p>
<p style="top:543.7pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:6.5pt">Table 2</span></p>
<p style="top:552.3pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Principal endpoints of studies evaluating Human recombinant activated protein C in experimental acute pancreatitis. rhAPC</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Human recombinant Activated Protein C;</span></p>
<p style="top:560.8pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AP</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Acute pancreatitis; TNF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt">a</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Tumor necrosis factor alpha; IL-6</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Interleukin-6; MPO</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Myeloperoxidase; MAPK</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> mitogen-activated protein kinases; mRNA</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> messenger</span></p>
<p style="top:569.4pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ribonucleic acid; JNK</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> c-Jun N-terminal Kinases; ERK 1/2</span><span style="font-family:AdvP4C4E74,serif;font-size:6.5pt"> &#xbc;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> Extracellular signal-regulated Kinases.</span></p>
<p style="top:583.6pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">First author</span></p>
<p style="top:583.6pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Study</span></p>
<p style="top:583.6pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Principal endpoints</span></p>
<p style="top:595.0pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Yamanel</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [18]</span></p>
<p style="top:595.0pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Effect of rhAPC on AP.</span></p>
<p style="top:595.0pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC associated with marked reduction in pancreatic edema, necrosis without increase in hemorrhage.</span></p>
<p style="top:603.6pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC ameliorated serum amylase, TNF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:7.0pt">a</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> and IL-6.</span></p>
<p style="top:612.1pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC associated with a reduction in bacterial translocation to mesenteric nodes.</span></p>
<p style="top:620.7pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [17]</span></p>
<p style="top:620.7pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Safety assessment.</span></p>
<p style="top:620.7pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Concentration-dependent thrombocytopenia.</span></p>
<p style="top:629.3pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No evidence of bleeding.</span></p>
<p style="top:637.9pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [17]</span></p>
<p style="top:637.9pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Treatment of severe AP.</span></p>
<p style="top:637.9pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No difference in histologic scores of necrosis and edema.</span></p>
<p style="top:646.4pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cant reduction in pancreatic and pulmonary MPO.</span></p>
<p style="top:655.0pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [17]</span></p>
<p style="top:655.0pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC and survival.</span></p>
<p style="top:655.0pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6 of 7 (86%) survival in rhAPC group</span></p>
<p style="top:663.6pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3 of 8 (38%) in AP group.</span></p>
<p style="top:672.1pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Chen</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [19]</span></p>
<p style="top:672.1pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Effect of rhAPC on MAPK.</span></p>
<p style="top:672.1pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC-treatment resulted in reduction of histological evidence of pancreatic injury.</span></p>
<p style="top:680.7pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC-treatment was associated with decreased gene, mRNA and protein expression of p38 MAPK and JNK</span></p>
<p style="top:689.3pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">with increased expression of ERK1/2.</span></p>
<p style="top:697.9pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC-treatment resulted in lower histological scores of pancreatic injury (including necrosis).</span></p>
<p style="top:706.4pt;left:48.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Akay</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt;color:#000066"> [20]</span></p>
<p style="top:706.4pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Effect of rhAPC on early</span></p>
<p style="top:715.0pt;left:118.2pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">phase of acute pancreatitis.</span></p>
<p style="top:706.4pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Mean serum amylase lower in treatment group.</span></p>
<p style="top:715.0pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No difference in histopathologic scores of injury.</span></p>
<p style="top:723.6pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No difference in pancreatic MPO activity.</span></p>
<p style="top:732.1pt;left:229.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">No difference in serum interleukin-6 concentrations.</span></p>
<p style="top:47.8pt;left:226.8pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">C.J. Miranda et al. / Pancreatology 12 (2012) 119</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">123</span></p>
<p style="top:47.8pt;left:552.1pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">121</span></p>


<p style="top:66.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a report detailing their experience with human recombinant</span></p>
<p style="top:76.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">activated protein C in the treatment of a patient with pancrea-</span></p>
<p style="top:87.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">titis following the receipt of a transplanted pancreas</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [24]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">.</span></p>
<p style="top:97.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Rybicki and colleagues report a further case treated with rhAPC</span></p>
<p style="top:108.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">because of rapidly progressive multiple organ failure</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [25]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. All</span></p>
<p style="top:118.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">case reports describe a favorable outcome with no evidence of</span></p>
<p style="top:128.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatment-related hemorrhage but clearly provide only limited</span></p>
<p style="top:139.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">evidence.</span></p>
<p style="top:170.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">4. Discussion</span></p>
<p style="top:191.7pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">This report assesses the evidence for the evaluation of rhAPC as</span></p>
<p style="top:202.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a disease modifying drug in acute pancreatitis. As with almost all</span></p>
<p style="top:212.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">other proposed disease modifying drugs, a body of evidence has</span></p>
<p style="top:223.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">accrued from studies in experimental acute pancreatitis. Placed</span></p>
<p style="top:233.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">together, rather than read in isolation, the relative similarities and</span></p>
<p style="top:243.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">disparities of protocol design become readily evident (</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">Tables 1 and</span></p>
<p style="top:254.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">2</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">). The four studies featured here all use the rat model of intra-</span></p>
<p style="top:264.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ductal sodium taurocholate infusion. An advantage of this model</span></p>
<p style="top:275.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">is its reproducibility and the resultant severe acute necrotizing</span></p>
<p style="top:285.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [26]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. A theoretical disadvantage is the physical manip-</span></p>
<p style="top:296.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ulation of the pancreas in relation to assessment of an intervention,</span></p>
<p style="top:306.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">which has pancreatic hemorrhage as a potential side effect. The</span></p>
<p style="top:317.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">concentration of rhAPC used in the intervention groups and criti-</span></p>
<p style="top:327.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cally, the timing of intervention, vary considerably between studies.</span></p>
<p style="top:338.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">We have previously reported that studies of experimental acute</span></p>
<p style="top:348.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis can be broadly dichotomized into those that examine</span></p>
<p style="top:359.0pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mechanistic components of the pancreatic in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory process</span></p>
<p style="top:369.5pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and those that evaluate a potential speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c therapy</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [27]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. In this</span></p>
<p style="top:379.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">regard, the Alsfasser study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> is well-designed and executed and</span></p>
<p style="top:390.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reports a composite of a series of studies and is the sole experi-</span></p>
<p style="top:400.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mental study to evaluate the effect of rhAPC on mortality. As such,</span></p>
<p style="top:411.4pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">although there is no formal process of weighting the importance of</span></p>
<p style="top:421.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">experimental studies, the Alsfasser study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings carry</span></p>
<p style="top:432.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">considerable importance and their key</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nding of a reduction in</span></p>
<p style="top:442.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">mortality from 86% in the AP group to 38% in the AP group treated</span></p>
<p style="top:453.2pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with rhAPC (at that time termed Drotrecogin Alfa) without evidence</span></p>
<p style="top:463.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of bleeding is noteworthy. The failure to modify the histological</span></p>
<p style="top:474.1pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">features of pancreatic injury raises the possibility that bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cial</span></p>
<p style="top:484.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">effects of rhAPC are from actions out with the pancreas. The studies</span></p>
<p style="top:495.0pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of Yamanel</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [18]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and Chen</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [19]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> are broadly supportive of Alsfasser</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s</span></p>
<p style="top:505.5pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Yamanel</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [18]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> work contrasts with Alsfasser</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> in</span></p>
<p style="top:516.0pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">demonstrating histological evidence of amelioration of pancreatic</span></p>
<p style="top:526.4pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">injury in animals with AP treated with rhAPC.</span></p>
<p style="top:536.9pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings of the Akay</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [20]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> study, which had intervention with</span></p>
<p style="top:547.3pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rhAPC at 4 h in a 9 h protocol, reported no bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cial effect. This</span></p>
<p style="top:557.8pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">apparent disparity may relate to the relatively late timing of</span></p>
<p style="top:568.2pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">intervention in a model with a compressed time course. The studies</span></p>
<p style="top:578.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of rhAPC in experimental acute pancreatitis can be summated as</span></p>
<p style="top:589.2pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">showing no evidence of pancreatic or remote hemorrhage as</span></p>
<p style="top:599.7pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a consequence of treatment with 3 of 4 studies showing an</span></p>
<p style="top:610.1pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">amelioration of pancreatic injury as a consequence of the inter-</span></p>
<p style="top:620.6pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">vention. The Alsfasser study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> provides key evidence of reduc-</span></p>
<p style="top:631.1pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tion in mortality with treatment and taken together this body of</span></p>
<p style="top:641.5pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">experimental evidence justi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">es progression to clinical evaluation of</span></p>
<p style="top:652.0pt;left:32.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rhAPC as a speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c disease modifying drug in SAP.</span></p>
<p style="top:662.4pt;left:44.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">A particular interest with rhAPC is the interaction between its</span></p>
<p style="top:672.9pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">anticoagulant role and its anti-in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory properties. In the</span></p>
<p style="top:683.3pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Alsfasser study, there were signi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cant anti-in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory proper-</span></p>
<p style="top:693.8pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ties manifest by a reduction in myeloperoxidase</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. Chen and</span></p>
<p style="top:704.2pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">colleagues also demonstrated a reduction in pro-in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory</span></p>
<p style="top:714.7pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cytokines</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [21]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">. At the present time, there are insuf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient data to</span></p>
<p style="top:725.1pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">differentiate with certainty whether the bene</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cial effects of rhAPC</span></p>
<p style="top:735.6pt;left:32.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in experimental acute pancreatitis are effected predominantly by</span></p>
<p style="top:66.1pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">modulation of microvascular thrombosis, down regulation of</span></p>
<p style="top:76.6pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammation or a combination of both.</span></p>
<p style="top:87.0pt;left:313.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">This off license role of the drug was evaluated in a well-designed</span></p>
<p style="top:97.5pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">and well-executed study undertaken by the Helsinki group (APCAP</span></p>
<p style="top:108.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">[22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">). Set against a contemporary backdrop of imminent re-</span></p>
<p style="top:118.4pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">categorization of the terminology around the severity of acute</span></p>
<p style="top:128.9pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis, the Kemppainen</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> study clearly identi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">es a cohort</span></p>
<p style="top:139.3pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of patients with clinically severe acute pancreatitis (16 patients in</span></p>
<p style="top:149.8pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the intervention arm had an APACHE II score of 17.6</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 8.5 and</span></p>
<p style="top:160.2pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a median age of 47</span><span style="font-family:AdvP4C4E74,serif;font-size:8.1pt"> &#xfffd;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> 8 years). They clearly learned the lesson of the</span></p>
<p style="top:170.7pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">lexipafant intervention study</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [28]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> and avoided recruiting a pop-</span></p>
<p style="top:181.2pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ulation where there was a disproportionate in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">uence of the chronic</span></p>
<p style="top:191.7pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">health evaluation component of the APACHE II score. APCAP is also</span></p>
<p style="top:202.1pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">realistic and reasonable in looking for reduction in organ failure</span></p>
<p style="top:212.6pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">score as a primary endpoint rather than an effect on mortality. The</span></p>
<p style="top:223.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">problem with small group intervention studies is that a single</span></p>
<p style="top:233.5pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">adverse outcome (such as death after laparotomy) will have</span></p>
<p style="top:243.9pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a disproportionate skewing effect on interpretation of endpoints.</span></p>
<p style="top:254.4pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">As such, we would concur completely with the Kemppainen</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span></p>
<p style="top:264.9pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">group</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s own conclusion that their study showed no serious</span></p>
<p style="top:275.3pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">hemorrhagic events associated with intervention but also no</span></p>
<p style="top:285.8pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">evidence of treatment-induced modi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cation in the evolution of</span></p>
<p style="top:296.3pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">organ dysfunction. However, with a treatment arm of just 16</span></p>
<p style="top:306.8pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients, this question clearly remains unanswered.</span></p>
<p style="top:317.2pt;left:313.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Little substantial additional information derives from the other</span></p>
<p style="top:327.7pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">anecdotal case reports.</span></p>
<p style="top:338.1pt;left:313.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">The logical question to answer in progressing the assessment of</span></p>
<p style="top:348.6pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rhAPC is whether the position of clinical equipoise in relation to</span></p>
<p style="top:359.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">intervention has been reached, currently exists or has passed. In</span></p>
<p style="top:369.5pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">this context, the experimental evidence clearly makes a case for</span></p>
<p style="top:380.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">evaluation and the carefully executed Kemppainen</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> study takes</span></p>
<p style="top:390.4pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">the body of evidence forward but the nature of its negative result</span></p>
<p style="top:400.9pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">means that currently, equipoise has not been reached. Put in the</span></p>
<p style="top:411.4pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">context of the important moral aspect of contemporary trial design,</span></p>
<p style="top:421.8pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">it remains unethical to randomize large numbers of patients with</span></p>
<p style="top:432.3pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">SAP to receive rhAPC in an intervention arm, in the absence of</span></p>
<p style="top:442.7pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">suf</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cient clinical evidence to justify altering any given individual</span><span style="font-family:AdvOT863180fb+20,serif;font-size:8.1pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">s</span></p>
<p style="top:453.2pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">treatment from standard care.</span></p>
<p style="top:463.6pt;left:313.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">However, a rational argument can be made for a smaller,</span></p>
<p style="top:474.1pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">randomized, placebo-controlled evaluation of rhAPC in SAP. As</span></p>
<p style="top:484.6pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with APCAP</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, the de</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nition of severity must provide informa-</span></p>
<p style="top:495.1pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">tion on APACHE II score, disease duration, organ dysfunction and</span></p>
<p style="top:505.5pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">systemic in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory response as these allow later workers to</span></p>
<p style="top:516.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">categorize the severity of the disease. Although doses in excess of</span></p>
<p style="top:526.4pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">24</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.7pt"> m</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">g/kg/h may be of interest, as anti-in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory activity</span></p>
<p style="top:536.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">appears to be dose related, the weight of clinical safety data related</span></p>
<p style="top:547.3pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">to the sepsis treatment dose suggests that any higher concentration</span></p>
<p style="top:557.8pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">could not readily be justi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed.</span></p>
<p style="top:568.2pt;left:313.7pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Critical issues remain around primary endpoint and power</span></p>
<p style="top:578.7pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">calculation. In a placebo-controlled evaluation of a drug with</span></p>
<p style="top:589.1pt;left:301.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">complex, whole-organ, anti-in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory effects, a meaningful</span></p>
<p style="top:599.6pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">endpoint could be reduction in critical care occupancy. Given the</span></p>
<p style="top:610.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">negative</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings of the APCAP</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> study, it is probably unwise to</span></p>
<p style="top:620.5pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">construct a power calculation on the Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ndings and</span></p>
<p style="top:631.0pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a pragmatic compromise based on recruitment rates is realistic</span></p>
<p style="top:641.5pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">(bearing in mind that the APCAP investigators screened 215</span></p>
<p style="top:651.9pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patients to recruit 32). A practical primary endpoint would be</span></p>
<p style="top:662.4pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reduction in critical care occupancy.</span></p>
<p style="top:672.9pt;left:313.8pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">In conclusion, the experimental evidence underlying a potential</span></p>
<p style="top:683.3pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">role for rhAPC as a speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c disease modifying drug in acute</span></p>
<p style="top:693.8pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">pancreatitis makes a strong but not conclusive case for evaluation.</span></p>
<p style="top:704.2pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Set in the context of the lexipafant studies of the 1990s</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [29</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt;color:#000066">e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066">32]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">, the</span></p>
<p style="top:714.7pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">experimental evidence is probably stronger for rhAPC than existed</span></p>
<p style="top:725.1pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">for lexipafant. The single clinical randomized trial</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [22]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> strikes an</span></p>
<p style="top:735.6pt;left:301.9pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">important cautionary note as it is both well-designed and well-</span></p>
<p style="top:47.8pt;left:217.1pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">C.J. Miranda et al. / Pancreatology 12 (2012) 119</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">123</span></p>
<p style="top:47.8pt;left:32.8pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">122</span></p>


<p style="top:66.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">executed. Set against a background of the knowledge of the</span></p>
<p style="top:76.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">increasing complexity of the biology of clinical sepsis and the</span></p>
<p style="top:87.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">continuing uncertainty over the clinical validity of rhAPC, the point</span></p>
<p style="top:97.5pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of equipoise to justify a major randomized trial has not been</span></p>
<p style="top:108.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">reached. Yet, the Alsfasser</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt;color:#000066"> [17]</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> evidence remains important and the</span></p>
<p style="top:118.4pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">prospect</span></p>
<p style="top:118.4pt;left:82.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">of</span></p>
<p style="top:118.4pt;left:97.3pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a</span></p>
<p style="top:118.4pt;left:109.0pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c</span></p>
<p style="top:118.4pt;left:144.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">disease</span></p>
<p style="top:118.4pt;left:179.4pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">modifying</span></p>
<p style="top:118.4pt;left:225.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">drug</span></p>
<p style="top:118.4pt;left:250.6pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">with</span></p>
<p style="top:118.4pt;left:275.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">anti-</span></p>
<p style="top:128.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ammatory actions and a role in preservation of microvascular</span></p>
<p style="top:139.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">patency cannot be ignored.</span></p>
<p style="top:149.8pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">As a result of the negative outcome of the current PROWESS</span></p>
<p style="top:160.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">SHOCK study, rhAPC has currently been withdrawn from clinical</span></p>
<p style="top:170.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">use (Eli Lilly</span><span style="font-family:AdvPS44A44B,serif;font-size:8.1pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt"> personal communication). The withdrawal was</span></p>
<p style="top:181.2pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">made on the grounds of lack of ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">cacy in overwhelming sepsis</span></p>
<p style="top:191.7pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">rather than on safety grounds thus disease-speci</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">c evaluation in</span></p>
<p style="top:202.1pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">a setting such as severe acute pancreatitis remains an option.</span></p>
<p style="top:212.6pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">Further clinical evaluation is justi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">ed and supported by the</span></p>
<p style="top:223.0pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">evidence summated in this report.</span></p>
<p style="top:243.9pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">Financial support</span></p>
<p style="top:264.9pt;left:54.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">AKS has received</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:8.1pt"> &#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">nancial support from Eli Lilly, Indianapolis</span></p>
<p style="top:275.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOT863180fb,serif;font-size:8.1pt">USA for the XIGAP-1 study.</span></p>
<p style="top:296.3pt;left:42.5pt;line-height:8.1pt"><span style="font-family:AdvOTb83ee1dd.B,serif;font-size:8.1pt">References</span></p>
<p style="top:315.6pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[1] Bradley E. A clinically based classi</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cation system for acute pancreatitis.</span></p>
<p style="top:323.6pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Summary of the international symposium on acute pancreatitis, Atlanta, GA,</span></p>
<p style="top:331.6pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">September 11 through 13, 1992. Arch Surg 1993;128:586</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">90.</span></p>
<p style="top:339.5pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[2] Working Party of the British Society of Gastroenterology, Association of</span></p>
<p style="top:347.5pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain and</span></p>
<p style="top:355.4pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Ireland, Association of Upper GI Surgeons of Great Britain and Ireland. UK</span></p>
<p style="top:363.4pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">guidelines for the management of acute pancreatitis. Gut 2005;54(Suppl. 3):</span></p>
<p style="top:371.4pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">iii1</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9.</span></p>
<p style="top:379.4pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[3] Banks P, Freeman M. Practice guidelines in acute pancreatitis. Am J Gastro-</span></p>
<p style="top:387.4pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">enterol 2006;101:2379</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">400.</span></p>
<p style="top:395.3pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[4] Bassi C, Falconi M, Talamini G, Uomo G, Papaccio G, Dervenis C, et al.</span></p>
<p style="top:403.3pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Controlled clinical trial of pe</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">oxacin versus imipenem in severe acute</span></p>
<p style="top:411.3pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatitis. Gastroenterology 1998;115:1513</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">7.</span></p>
<p style="top:419.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[5] Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L,</span></p>
<p style="top:427.2pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Valtonen V, et al. Early antibiotic treatment in acute necrotising pancreatitis.</span></p>
<p style="top:435.2pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lancet 1995;346:663</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">7.</span></p>
<p style="top:443.2pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[6] Isenmann R, R&#xfc;nzi M, Kron M, Kahl S, Kraus D, Jung N, et al. Prophylactic</span></p>
<p style="top:459.1pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">a</span><sup><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">antibiotic treatment in patients with predicted severe acute pancreatitis:</span></sup></p>
<p style="top:459.1pt;left:69.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">placebo-controlled,</span></p>
<p style="top:459.1pt;left:135.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">double-blind</span></p>
<p style="top:459.1pt;left:181.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">trial.</span></p>
<p style="top:459.1pt;left:202.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Gastroenterology</span></p>
<p style="top:459.1pt;left:262.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2004;126:</span></p>
<p style="top:467.1pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">997</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">1004.</span></p>
<p style="top:475.0pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[7] Petrov MS, Loveday BP, Pylypchuk RD, McIlroy K, Phillips AR, Windsor JA.</span></p>
<p style="top:483.0pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Systematic review and meta-analysis of enteral nutrition formulations in</span></p>
<p style="top:491.0pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">acute pancreatitis. Br J Surg 2009;96:1243</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">52.</span></p>
<p style="top:498.9pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[8] Powell JJ, Murchison JT, Fearon KC, Ross JA, Siriwardena AK. Randomized</span></p>
<p style="top:506.9pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">controlled trial of the effect of early enteral nutrition on markers of the</span></p>
<p style="top:514.9pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ammatory response in predicted severe acute pancreatitis. Br J Surg 2000;</span></p>
<p style="top:522.9pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">87:1375</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">81.</span></p>
<p style="top:530.8pt;left:45.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[9] Nitsche R, Folsch UR. Role of ERCP and endoscopic sphincterotomy in acute</span></p>
<p style="top:538.8pt;left:58.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999;13:331</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">43.</span></p>
<p style="top:546.7pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[10] Tsiotos G, Luque-de Leon E, Sarr M. Long-term outcome of necrotizing</span></p>
<p style="top:554.7pt;left:58.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatitis treated by necrosectomy. Br J Surg 1998;85:1650</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">3.</span></p>
<p style="top:562.7pt;left:42.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[11] Will U, Wegener C, Graf K, Wanzar I, Manger T, Meyer F. Differential treat-</span></p>
<p style="top:570.7pt;left:58.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ment and early outcome in the interventional endoscopic management of</span></p>
<p style="top:578.7pt;left:58.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatic pseudocysts in 27 patients. World J Gastroenterol 2006;12:</span></p>
<p style="top:586.6pt;left:58.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">4175</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">8.</span></p>
<p style="top:66.3pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[12] Esmon CT. Crosstalk between in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ammation and thrombosis. Maturitas 2004;</span></p>
<p style="top:74.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">47:305</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">14.</span></p>
<p style="top:82.2pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[13] Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation</span></p>
<p style="top:90.2pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">in sepsis. Chest 2005;128:2864</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">75.</span></p>
<p style="top:98.1pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[14] Esmon CT. Protein C anticoagulant pathway and its role in controlling</span></p>
<p style="top:106.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">microvascular thrombosis and in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ammation. Crit Care Med 2001;29:S48</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">51</span></p>
<p style="top:114.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[discussion 51</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">42].</span></p>
<p style="top:122.1pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[15] Taylor Jr FB, Chang A, Esmon CT, D</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Angelo A, Vigano-D</span><span style="font-family:AdvOT863180fb+20,serif;font-size:6.5pt">&#x2019;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Angelo S, Blick KE.</span></p>
<p style="top:130.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Protein C prevents the coagulopathic and lethal effects of</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.5pt"> Escherichia coli</span></p>
<p style="top:138.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">infusion in the baboon. J Clin Invest 1987;79:918</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">25.</span></p>
<p style="top:146.0pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[16] Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A,</span></p>
<p style="top:153.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al. Ef</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb01;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">cacy and safety of recombinant human activated protein c for severe</span></p>
<p style="top:161.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">sepsis. N Engl J Med 2001;344:699</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">709.</span></p>
<p style="top:169.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[17] Alsfasser</span></p>
<p style="top:169.9pt;left:362.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">G,</span></p>
<p style="top:169.9pt;left:376.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Warshaw</span></p>
<p style="top:169.9pt;left:413.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">AL,</span></p>
<p style="top:169.9pt;left:430.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Thayer</span></p>
<p style="top:169.9pt;left:458.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">SP,</span></p>
<p style="top:169.9pt;left:475.1pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Antoniu</span></p>
<p style="top:169.9pt;left:507.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">B,</span></p>
<p style="top:169.9pt;left:520.7pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Laposata</span></p>
<p style="top:169.9pt;left:554.9pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">M,</span></p>
<p style="top:177.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Lewandrowski KB, et al. Decreased in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ammation and improved survival with</span></p>
<p style="top:185.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">recombinant human activated protein C treatment in experimental acute</span></p>
<p style="top:193.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatitis. Arch Surg 2006;141:670</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6.</span></p>
<p style="top:201.7pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[18] Yamanel L, Yamenel L, Mas MR, Comert B, Isik AT, Aydin S, et al. The effect of</span></p>
<p style="top:209.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">activated protein C on experimental acute necrotizing pancreatitis. Crit Care</span></p>
<p style="top:217.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2005;9:R184</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">90.</span></p>
<p style="top:225.7pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[19] Chen P, Zhang Y, Qiao M, Yuan Y. Activated protein C, an anticoagulant</span></p>
<p style="top:233.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">polypeptide, ameliorates severe acute pancreatitis via regulation of mitogen-</span></p>
<p style="top:241.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">activated protein kinases. J Gastroenterol 2007;42:887</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">96.</span></p>
<p style="top:249.6pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[20] Akay S, Ozutemiz O, Yenisey C, Genc Simsek N, Yuce G, Batur Y. Use of acti-</span></p>
<p style="top:257.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">vated protein C has no avail in the early phase of acute pancreatitis. HPB</span></p>
<p style="top:265.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">(Oxford) 2008;10:459</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">63.</span></p>
<p style="top:273.5pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[21] Ping C, Yongping Z, Minmin Q, Weiyan Y, Yaozong Y. Activated protein C</span></p>
<p style="top:281.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">improves the severity of severe acute pancreatitis via up-regulating the</span></p>
<p style="top:289.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">expressions of endothelial cell protein C receptor and thrombomodulin. Dig</span></p>
<p style="top:297.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Dis Sci 2010;55:1599</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">609.</span></p>
<p style="top:305.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[22] Pettil&#xe4; V, Kyh&#xe4;l&#xe4; L, Kyl&#xe4;np&#xe4;&#xe4; M-L, Lepp&#xe4;niemi A, Tallgren M, Markkola A, et al.</span></p>
<p style="top:313.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">APCAP</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> activated protein C in acute pancreatitis: a double-blind randomized</span></p>
<p style="top:321.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">human pilot trial. Crit Care 2010;14. R139</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">R137.</span></p>
<p style="top:329.3pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[23] Machala W, Wachowicz N, Komorowska A, Gaszynski W. The use of dro-</span></p>
<p style="top:337.3pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">trecogin alfa (activated) in severe sepsis during acute pancreatitis</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt"> e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt"> two case</span></p>
<p style="top:345.2pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">studies. Med Sci Monit 2004;10:CS31</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6.</span></p>
<p style="top:353.2pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[24] Grochowiecki T, Nazarewski S, Meszaros J, Kanski A, Wojtaszek M, Kosinski C,</span></p>
<p style="top:361.2pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">et al. Use of drotrecogin alpha (recombinant human activated protein C,</span></p>
<p style="top:369.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">rhAPC) in the treatment of severe sepsis induced by graft pancreatitis after</span></p>
<p style="top:377.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">simultaneous pancreas and kidney transplantation: a case report. Transplant</span></p>
<p style="top:385.1pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Proc 2006;38:276</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9.</span></p>
<p style="top:393.0pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[25] Rybicki Z, Truszczynski A, Skibinski M. Recombinant human activated protein</span></p>
<p style="top:401.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">C administered twice to the same patient with shock caused by the acute</span></p>
<p style="top:409.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatitis and with septic shock as iatrogenic complication. Pol Przegl Chir</span></p>
<p style="top:417.0pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">2007;79:80</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6.</span></p>
<p style="top:424.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[26] Case RM. Is the rat pancreas an appropriate model of the human pancreas?</span></p>
<p style="top:432.9pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Pancreatology 2006;6:180</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">90.</span></p>
<p style="top:440.9pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[27] Mason JM, Siriwardena AK. Designing future trials in acute pancreatitis.</span></p>
<p style="top:448.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Pancreatology 2005;5:113</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5.</span></p>
<p style="top:456.8pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[28] Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP,</span></p>
<p style="top:464.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">McKay C, et al. Double blind, randomised, placebo controlled study of</span></p>
<p style="top:472.8pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">a platelet activating factor antagonist, lexipafant, in the treatment and</span></p>
<p style="top:480.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">prevention of organ failure in predicted severe acute pancreatitis. Gut 2001;</span></p>
<p style="top:488.7pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">48:62</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">9.</span></p>
<p style="top:496.7pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[29] Zhou W, Levine BA, Olson MS. Platelet-activating factor: a mediator of</span></p>
<p style="top:504.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatic in</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">ammation during cerulein hyperstimulation. Am J Pathol 1993;</span></p>
<p style="top:512.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">142:1504</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">12.</span></p>
<p style="top:520.6pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[30] Leonhardt</span></p>
<p style="top:520.6pt;left:364.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">U,</span></p>
<p style="top:520.6pt;left:376.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Fayyazzi</span></p>
<p style="top:520.6pt;left:408.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">A,</span></p>
<p style="top:520.6pt;left:419.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Seidensticker</span></p>
<p style="top:520.6pt;left:466.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">F,</span></p>
<p style="top:520.6pt;left:476.6pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Stockmann</span></p>
<p style="top:520.6pt;left:516.3pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">F,</span></p>
<p style="top:520.6pt;left:527.0pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Soling</span></p>
<p style="top:520.6pt;left:551.4pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">HD,</span></p>
<p style="top:528.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Creutzfeldt W. In</span><span style="font-family:AdvOT863180fb+fb,serif;font-size:6.5pt">&#xfb02;</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">uence of a platelet-activating factor antagonist on severe</span></p>
<p style="top:536.6pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">pancreatitis in two experimental models. Int J Pancreatol 1992;12:161</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">6.</span></p>
<p style="top:544.5pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[31] Formela LJ, Wood LM, Whittaker M, Kingsnorth AN. Amelioration of experi-</span></p>
<p style="top:552.5pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">mental acute pancreatitis with a potent platelet-activating factor antagonist.</span></p>
<p style="top:560.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">Br J Surg 1994;81:1783</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">5.</span></p>
<p style="top:568.4pt;left:311.5pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">[32] Albert DH, Conway RG, Magoc TJ, Tapang P, Rhein DA, Luo G, et al. Properties</span></p>
<p style="top:576.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor</span></p>
<p style="top:584.4pt;left:327.8pt;line-height:6.5pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">receptor antagonist. J Pharmacol Exp Ther 1996;277:1595</span><span style="font-family:AdvPS44A44B,serif;font-size:6.5pt">e</span><span style="font-family:AdvOT863180fb,serif;font-size:6.5pt">606.</span></p>
<p style="top:47.8pt;left:226.8pt;line-height:6.4pt"><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">C.J. Miranda et al. / Pancreatology 12 (2012) 119</span><span style="font-family:AdvPS44A44B,serif;font-size:6.4pt">e</span><span style="font-family:AdvOTb92eb7df.I,serif;font-size:6.4pt">123</span></p>
<p style="top:47.8pt;left:551.9pt;line-height:6.4pt"><span style="font-family:AdvOT863180fb,serif;font-size:6.4pt">123</span></p>

</div>
